Ge Healthcare Drug Patent Portfolio
Ge Healthcare owns 5 orange book drugs protected by 15 US patents with Datscan having the least patent protection, holding only 1 patent. And Flyrcado with maximum patent protection, holding 6 patents. Given below is the list of Ge Healthcare's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9687571 | Stabilization of radiopharmaceutical compositions using ascorbic acid | 01 Nov, 2032 | Active |
| US8936777 | Methods and apparatus for synthesizing imaging agents, and intermediates thereof | 30 Jun, 2031 | Active |
| US9603951 | Methods and apparatus for synthesizing imaging agents, and intermediates thereof | 02 May, 2031 | Active |
| US8916131 | Radiopharmaceutical composition | 16 Sep, 2028 | Active |
| US8226929 | Contrast agents for myocardial perfusion imaging | 21 Jun, 2028 | Active |
| US7344702 | Contrast agents for myocardial perfusion imaging | 26 May, 2026 | Active |
| US9161997 | Contrast agents for myocardial perfusion imaging | 04 Feb, 2026 | Active |
| US7270800 | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition | 03 Sep, 2025 | Expired |
| US8236282 | Benzothiazole derivative compounds, compositions and uses | 21 May, 2024 | Expired |
| US7351401 | Thioflavin derivatives for use in the antemortem diagnosis of Alzheimers disease and in vivo imaging and prevention of amyloid deposition | 24 Jan, 2023 | Expired |
| US8691185 | Benzothiazole derivative compounds, compositions and uses | 24 Jan, 2023 | Expired |
| US6723303 | Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane | 20 Apr, 2021 | Expired |
| US5560903 | Method of enhancing paramagnetism in chelates for MRI | 01 Oct, 2013 | Expired |
| US5529766 | Contrast agents | 25 Jun, 2013 | Expired |
| US5310912 | Iodinated neuroprobe for mapping monoamine reuptake sites | 25 Feb, 2013 | Expired |
Latest Legal Activities on Ge Healthcare's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ge Healthcare.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 25 Jan, 2024 | US8236282 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 19 May, 2022 | US8916131 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 22 Sep, 2021 | US8691185 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 23 Jan, 2020 | US8236282 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Sep, 2019 | US7351401 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 07 Mar, 2019 | US7270800 |
| Post Issue Communication - Certificate of Correction | 27 Nov, 2018 | US7270800 |
| Post Issue Communication - Certificate of Correction | 14 Nov, 2018 | US8236282 |
| Post Issue Communication - Certificate of Correction | 07 Nov, 2018 | US8691185 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 25 Jun, 2018 | US8916131 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 21 Sep, 2017 | US8691185 |
|
Patent Term Extension Certificate
Critical
| 21 Mar, 2017 | US7270800 |
| Notice of Final Determination -Eligible | 07 Dec, 2016 | US7270800 |
|
FDA Final Eligibility Letter
Critical
| 29 Jul, 2016 | US7270800 |
| transaction for FDA Determination of Regulatory Review Period | 15 Dec, 2015 | US7270800 |
Ge Healthcare's Drug Patent Litigations
Ge Healthcare's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Mar 28, 2000, against patent number US6723303. The petitioner , challenged the validity of this patent, with QUAY as the respondent. Click below to track the latest information on how companies are challenging Ge Healthcare's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US6723303 | March, 2000 |
Decision
(30 Oct, 2003)
| QUAY | |
Ge Healthcare's Family Patents
Ge Healthcare Drug List
Given below is the complete list of Ge Healthcare's drugs and the patents protecting them.
1. Datscan
Datscan is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5310912 | Iodinated neuroprobe for mapping monoamine reuptake sites |
25 Feb, 2013
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Datscan's drug page
2. Flyrcado
Flyrcado is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9687571 | Stabilization of radiopharmaceutical compositions using ascorbic acid |
01 Nov, 2032
(6 years from now)
| Active |
| US8936777 | Methods and apparatus for synthesizing imaging agents, and intermediates thereof |
30 Jun, 2031
(5 years from now)
| Active |
| US9603951 | Methods and apparatus for synthesizing imaging agents, and intermediates thereof |
02 May, 2031
(5 years from now)
| Active |
| US8226929 | Contrast agents for myocardial perfusion imaging |
21 Jun, 2028
(2 years from now)
| Active |
| US7344702 | Contrast agents for myocardial perfusion imaging |
26 May, 2026
(4 months from now)
| Active |
| US9161997 | Contrast agents for myocardial perfusion imaging |
04 Feb, 2026
(20 days from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Flyrcado's drug page
3. Omniscan
Omniscan is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5560903 | Method of enhancing paramagnetism in chelates for MRI |
01 Oct, 2013
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Omniscan's drug page
4. Optison
Optison is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6723303 | Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane |
20 Apr, 2021
(4 years ago)
| Expired |
| US5529766 | Contrast agents |
25 Jun, 2013
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Optison's drug page
5. Vizamyl
Vizamyl is protected by 5 patents, out of which 4 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8916131 | Radiopharmaceutical composition |
16 Sep, 2028
(2 years from now)
| Active |
| US7270800 | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
03 Sep, 2025
(4 months ago)
| Expired |
| US8236282 | Benzothiazole derivative compounds, compositions and uses |
21 May, 2024
(1 year, 7 months ago)
| Expired |
| US7351401 | Thioflavin derivatives for use in the antemortem diagnosis of Alzheimers disease and in vivo imaging and prevention of amyloid deposition |
24 Jan, 2023
(2 years ago)
| Expired |
| US8691185 | Benzothiazole derivative compounds, compositions and uses |
24 Jan, 2023
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vizamyl's drug page